Actively Recruiting

Phase 2
Age: 12Years +
All Genders
NCT07088926

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Led by AstraZeneca · Updated on 2026-05-07

435

Participants Needed

183

Research Sites

135 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.

CONDITIONS

Official Title

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Who Can Participate

Age: 12Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant must be 63 12 years of age at the time of signing the informed consent/assent
  • Weight 63 35 kg
  • Bronchiectasis diagnosed by a physician and confirmed by CT demonstrating abnormal bronchial dilation in 63 1 lobe; historical CT within 5 years acceptable or CT at screening
  • Receiving standard of care therapy with documented history of 63 2 moderate or 63 1 severe exacerbations requiring antibiotics in past 12 months
  • Clinically stable and free from bronchiectasis exacerbation for 4 weeks before randomization
  • Pre- or post-bronchodilator FEV1 63 25% predicted value at screening
  • Positive (PCR or culture) PsA in airway sample at least once in last 24 months prior to screening
  • Culture positive PsA in sputum within 5 weeks of randomization; prior PsA eradication therapy allowed if colonized
  • Capable of giving signed informed consent/assent and complying with protocol requirements
Not Eligible

You will not qualify if you...

  • Primary lung diagnosis other than bronchiectasis
  • Active tuberculosis or nontuberculous mycobacteria treated or needing treatment; treatment completed allowed
  • Active allergic bronchopulmonary aspergillosis treated or needing treatment
  • Need for long term supplemental oxygen; oxygen use for ambulation or exercise relief allowed
  • Current or recent malignancy within 5 years except stable prostate cancer, treated skin or cervical cancers
  • AIDS or advanced HIV disease with CD4 count < 200 cells/mm3
  • History of severe allergic reaction to monoclonal antibodies or immune complex disease
  • New long term anti-PsA antibiotics, macrolides, or DPP-1 inhibitors started within 3 months prior to screening
  • New chronic immunosuppressive therapy (prednisolone > 5 mg or equivalent) initiated within last 3 months
  • Receipt of investigational products for bronchiectasis exacerbations treatment or prevention
  • CF patients on CFTR modulator therapies started within previous 3 months
  • Female participants who are pregnant, lactating, or women of childbearing potential not using effective contraception or abstinence from 4 weeks before to 6 months after intervention

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 183 locations

1

Research Site

Orange, California, United States, 92868

Not Yet Recruiting

2

Research Site

San Francisco, California, United States, 94143

Actively Recruiting

3

Research Site

Denver, Colorado, United States, 80206

Not Yet Recruiting

4

Research Site

Washington D.C., District of Columbia, United States, 20007

Actively Recruiting

5

Research Site

Jacksonville, Florida, United States, 32209

Actively Recruiting

6

Research Site

Miami Lakes, Florida, United States, 33014

Suspended

7

Research Site

Naples, Florida, United States, 34102

Actively Recruiting

8

Research Site

Ormond Beach, Florida, United States, 32174

Actively Recruiting

9

Research Site

Plantation, Florida, United States, 33324

Actively Recruiting

10

Research Site

Rincon, Georgia, United States, 31326

Actively Recruiting

11

Research Site

Kansas City, Kansas, United States, 66160

Actively Recruiting

12

Research Site

Ann Arbor, Michigan, United States, 48109

Not Yet Recruiting

13

Research Site

Rochester, Minnesota, United States, 55905

Withdrawn

14

Research Site

St Louis, Missouri, United States, 63130

Actively Recruiting

15

Research Site

New York, New York, United States, 10016

Actively Recruiting

16

Research Site

New Bern, North Carolina, United States, 28562

Not Yet Recruiting

17

Research Site

Winston-Salem, North Carolina, United States, 27104

Not Yet Recruiting

18

Research Site

Tulsa, Oklahoma, United States, 74133

Withdrawn

19

Research Site

DuBois, Pennsylvania, United States, 15801

Withdrawn

20

Research Site

Philadelphia, Pennsylvania, United States, 19104

Not Yet Recruiting

21

Research Site

Charleston, South Carolina, United States, 29425

Not Yet Recruiting

22

Research Site

Rock Hill, South Carolina, United States, 29732

Actively Recruiting

23

Research Site

Austin, Texas, United States, 78705

Withdrawn

24

Research Site

Mansfield, Texas, United States, 76063

Actively Recruiting

25

Research Site

Ciudad de Buenos Aires, Argentina, C1180AAX

Actively Recruiting

26

Research Site

Florida, Argentina, B1602DQD

Actively Recruiting

27

Research Site

Rosario, Argentina, 2000

Actively Recruiting

28

Research Site

San Miguel de Tucumán, Argentina, 4000

Actively Recruiting

29

Research Site

Birtinya, Australia, 4575

Not Yet Recruiting

30

Research Site

Macquarie University, Australia, 2109

Not Yet Recruiting

31

Research Site

South Brisbane, Australia, 4101

Actively Recruiting

32

Research Site

Ghent, Belgium, 9000

Actively Recruiting

33

Research Site

Leuven, Belgium, 3000

Actively Recruiting

34

Research Site

Liège, Belgium, 4000

Actively Recruiting

35

Research Site

Sint-Niklaas, Belgium, 9100

Actively Recruiting

36

Research Site

Blumenau, Brazil, 89030-101

Actively Recruiting

37

Research Site

Campinas, Brazil, 13060-080

Actively Recruiting

38

Research Site

Curitiba, Brazil, 80030-110

Actively Recruiting

39

Research Site

Curitiba, Brazil, 80230-130

Not Yet Recruiting

40

Research Site

Porto Alegre, Brazil, 9061-000

Actively Recruiting

41

Research Site

Porto Alegre, Brazil, 90630-165

Not Yet Recruiting

42

Research Site

Porto Alegre, Brazil, 91350-200

Not Yet Recruiting

43

Research Site

Salvador, Brazil, 40050-410

Withdrawn

44

Research Site

São José dos Campos, Brazil, 12230-001

Not Yet Recruiting

45

Research Site

São Paulo, Brazil, 05.403-010

Not Yet Recruiting

46

Research Site

São Paulo, Brazil, 05403-000

Actively Recruiting

47

Research Site

Calgary, Alberta, Canada, T2N4Z6

Actively Recruiting

48

Research Site

Vancouver, British Columbia, Canada, V5Z 1M9

Actively Recruiting

49

Research Site

Ajax, Ontario, Canada, L1S 2J5

Actively Recruiting

50

Research Site

Stoney Creek, Ontario, Canada, L8G 2V6

Actively Recruiting

51

Research Site

Québec, Quebec, Canada, G1V 4G5

Actively Recruiting

52

Research Site

Saint-Charles-Borromée, Quebec, Canada, J6E 2B4

Actively Recruiting

53

Research Site

Trois-Rivières, Quebec, Canada, G8T 7A1

Withdrawn

54

Research Site

Concepción, Chile, 4070196

Not Yet Recruiting

55

Research Site

Santiago, Chile, 8150000

Not Yet Recruiting

56

Research Site

Santiago, Chile, 8380453

Not Yet Recruiting

57

Research Site

Talca, Chile, 3481349

Not Yet Recruiting

58

Research Site

Viña del Mar, Chile, 2540364

Not Yet Recruiting

59

Research Site

Aalborg, Denmark, 9000

Actively Recruiting

60

Research Site

Aarhus N, Denmark, 8200

Withdrawn

61

Research Site

Hvidovre, Denmark, 2650

Actively Recruiting

62

Research Site

Odense C, Denmark, 5000

Actively Recruiting

63

Research Site

Roskilde, Denmark, 4000

Actively Recruiting

64

Research Site

Brest, France, 29200

Actively Recruiting

65

Research Site

Créteil, France, 94010

Actively Recruiting

66

Research Site

Marseille, France, 13915

Not Yet Recruiting

67

Research Site

Montpellier, France, 34295

Actively Recruiting

68

Research Site

Paris, France, 75014

Actively Recruiting

69

Research Site

Pessac, France, 33604

Actively Recruiting

70

Research Site

Strasbourg, France, 67091

Actively Recruiting

71

Research Site

Toulouse, France, 31100

Actively Recruiting

72

Research Site

Darmstadt, Germany, 64283

Withdrawn

73

Research Site

Essen, Germany, 45239

Actively Recruiting

74

Research Site

Frankfurt, Germany, 60596

Actively Recruiting

75

Research Site

Halle, Germany, 06108

Actively Recruiting

76

Research Site

Hanover, Germany, 30625

Actively Recruiting

77

Research Site

Konstanz, Germany, 78464

Actively Recruiting

78

Research Site

München, Germany, 80336

Not Yet Recruiting

79

Research Site

München-Pasing, Germany, 81241

Actively Recruiting

80

Research Site

Athens, Greece, 11527

Actively Recruiting

81

Research Site

Athens, Greece, 12462

Actively Recruiting

82

Research Site

Athens, Greece, 15126

Actively Recruiting

83

Research Site

Athens, Greece, 17562

Actively Recruiting

84

Research Site

Ioannina, Greece, 45500

Actively Recruiting

85

Research Site

Larissa, Greece, 41110

Actively Recruiting

86

Research Site

Pátrai, Greece, 26500

Actively Recruiting

87

Research Site

Thessaloniki, Greece, 57010

Actively Recruiting

88

Research Site

Ashkelon, Israel, 7830604

Actively Recruiting

89

Research Site

Haifa, Israel, 34362

Actively Recruiting

90

Research Site

Jerusalem, Israel, 00000

Actively Recruiting

91

Research Site

Jerusalem, Israel, 91031

Actively Recruiting

92

Research Site

Ramat Gan, Israel, 52621

Actively Recruiting

93

Research Site

Tel Aviv, Israel, 6423906

Actively Recruiting

94

Research Site

Milan, Italy, 20122

Actively Recruiting

95

Research Site

Palermo, Italy, 90127

Actively Recruiting

96

Research Site

Pavia, Italy, 27100

Actively Recruiting

97

Research Site

Perugia, Italy, 06129

Actively Recruiting

98

Research Site

Roma, Italy, 00163

Actively Recruiting

99

Research Site

Rozzano, Italy, 20089

Actively Recruiting

100

Research Site

Torrette, Italy, 60126

Actively Recruiting

101

Research Site

Bunkyō City, Japan, 113-8655

Not Yet Recruiting

102

Research Site

Gifu, Japan, 500-8717

Not Yet Recruiting

103

Research Site

Hiratsuka-shi, Japan, 254-8502

Not Yet Recruiting

104

Research Site

Kamogawa-shi, Japan, 296-0041

Not Yet Recruiting

105

Research Site

Kiyose-shi, Japan, 204-8522

Not Yet Recruiting

106

Research Site

Kiyose-shi, Japan, 204-8585

Not Yet Recruiting

107

Research Site

Kurashiki-shi, Japan, 710-8602

Not Yet Recruiting

108

Research Site

Miyazaki, Japan, 889-1692

Not Yet Recruiting

109

Research Site

Nagasaki, Japan, 852-8501

Not Yet Recruiting

110

Research Site

Ogi, Japan, 845-0032

Not Yet Recruiting

111

Research Site

Shinjuku-ku, Japan, 160-8582

Not Yet Recruiting

112

Research Site

Shinjuku-ku, Japan, 162-8655

Not Yet Recruiting

113

Research Site

Urayasu-shi, Japan, 279-0021

Not Yet Recruiting

114

Research Site

Bandar Puncak Alam, Malaysia, 42300

Not Yet Recruiting

115

Research Site

Kuala Lumpur, Malaysia, 59100

Actively Recruiting

116

Research Site

Sibu, Malaysia, 96000

Actively Recruiting

117

Research Site

Amsterdam, Netherlands, 1081 HV

Not Yet Recruiting

118

Research Site

Rotterdam, Netherlands, 3015 GD

Not Yet Recruiting

119

Research Site

Zutphens, Netherlands, 7207 AE

Withdrawn

120

Research Site

Bellavista, Peru, CALLAO 2

Withdrawn

121

Research Site

Callao, Peru, Bellavista

Not Yet Recruiting

122

Research Site

Lima, Peru, 15023

Not Yet Recruiting

123

Research Site

Lima, Peru, 15036

Actively Recruiting

124

Research Site

Lima, Peru, 15038

Actively Recruiting

125

Research Site

Lima, Peru, 15082

Not Yet Recruiting

126

Research Site

Lima, Peru, 15088

Withdrawn

127

Research Site

Lima, Peru, LIMA 1

Actively Recruiting

128

Research Site

Lima, Peru, LIMA 29

Withdrawn

129

Research Site

Iloilo City, Philippines, 5000

Not Yet Recruiting

130

Research Site

Manila, Philippines, 1000

Not Yet Recruiting

131

Research Site

Quezon City, Philippines, 1100

Not Yet Recruiting

132

Research Site

Tondo, Philippines, 1012

Not Yet Recruiting

133

Research Site

Anyang-si, South Korea, 14068

Actively Recruiting

134

Research Site

Cheongju-si, South Korea, 28644

Actively Recruiting

135

Research Site

Daegu, South Korea, 42415

Actively Recruiting

136

Research Site

Seongnam-si, South Korea, 13620

Actively Recruiting

137

Research Site

Seoul, South Korea, 04763

Actively Recruiting

138

Research Site

Seoul, South Korea, 05030

Actively Recruiting

139

Research Site

Seoul, South Korea, 05505

Actively Recruiting

140

Research Site

Seoul, South Korea, 07441

Actively Recruiting

141

Research Site

Ulsan, South Korea, 44033

Actively Recruiting

142

Research Site

Barcelona, Spain, 08003

Actively Recruiting

143

Research Site

Barcelona, Spain, 08036

Actively Recruiting

144

Research Site

Benalmádena, Spain, 29631

Actively Recruiting

145

Research Site

Madrid, Spain, 28040

Actively Recruiting

146

Research Site

Madrid, Spain, 28046

Actively Recruiting

147

Research Site

Mérida, Spain, 06800

Not Yet Recruiting

148

Research Site

Patraix, Spain, 46017

Actively Recruiting

149

Research Site

Valencia, Spain, 46009

Actively Recruiting

150

Research Site

Kaohsiung City, Taiwan, 80756

Actively Recruiting

151

Research Site

Taichung, Taiwan, 40447

Actively Recruiting

152

Research Site

Taichung, Taiwan, 40705

Actively Recruiting

153

Research Site

Taipei, Taiwan, 0116

Actively Recruiting

154

Research Site

Taipei, Taiwan, 10002

Actively Recruiting

155

Research Site

Taipei, Taiwan, 110

Not Yet Recruiting

156

Research Site

Taoyuan, Taiwan, 333

Actively Recruiting

157

Research Site

Bang Kra So, Thailand, 11000

Actively Recruiting

158

Research Site

Bangkok, Thailand, 10400

Actively Recruiting

159

Research Site

Khon Kaen, Thailand, 40002

Actively Recruiting

160

Research Site

Muang, Thailand, 50200

Actively Recruiting

161

Research Site

Pathum Thani, Thailand, 12120

Actively Recruiting

162

Research Site

Adana, Turkey (Türkiye), 1330

Actively Recruiting

163

Research Site

Ankara, Turkey (Türkiye), 6340

Actively Recruiting

164

Research Site

Diyarbakır, Turkey (Türkiye), 21280

Actively Recruiting

165

Research Site

Istanbul, Turkey (Türkiye), 34098

Actively Recruiting

166

Research Site

Istanbul, Turkey (Türkiye), 34890

Actively Recruiting

167

Research Site

Mersin, Turkey (Türkiye), 33343

Actively Recruiting

168

Research Site

Zeytinburnu, Turkey (Türkiye), 34020

Actively Recruiting

169

Research Site

Belfast, United Kingdom, BT9 7AB

Actively Recruiting

170

Research Site

Birmingham, United Kingdom, B9 5SS

Actively Recruiting

171

Research Site

Brighton, United Kingdom, BN2 1ES

Actively Recruiting

172

Research Site

Cambridge, United Kingdom, CB2 0AY

Actively Recruiting

173

Research Site

Dundee, United Kingdom, DD1 9SY

Actively Recruiting

174

Research Site

Edinburgh, United Kingdom, EH16 4SA

Actively Recruiting

175

Research Site

Exeter, United Kingdom, EX2 5DW

Actively Recruiting

176

Research Site

Liverpool, United Kingdom, L14 3PE

Actively Recruiting

177

Research Site

Manchester, United Kingdom, M23 9LT

Actively Recruiting

178

Research Site

Can Tho, Vietnam, 900000

Not Yet Recruiting

179

Research Site

Haiphong, Vietnam, 180000

Not Yet Recruiting

180

Research Site

Hanoi, Vietnam, 100000

Not Yet Recruiting

181

Research Site

Hà Nội, Vietnam, 100000

Not Yet Recruiting

182

Research Site

Ho Chi Minh City, Vietnam, 700000

Not Yet Recruiting

183

Research Site

Huế, Vietnam, 530000

Not Yet Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization | DecenTrialz